| 1. | brianpitkin | |
| 2. | reformed4553 | |
| 3. | edesedyjy69fed | |
| 4. | andersenj182 | |
| 5. | mlaura |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | brianpitkin 01/26/2018 Company announced that new interim results from its ongoing Phase 1 clinical trial of MRG-106 in patients wi… |
| 2. | edesedyjy69fed 02/05/2018 perfect day for it, everything is dying |
| 3. | brianpitkin 02/05/2018 miRagen Therapeutics Announces Proposed Public Offering of Common Stock |
| 4. | edesedyjy69fed 02/08/2018 Prices 7 mln share common stock offering at $5.50 per share |
| 5. | reformed4553 02/05/2018 {Image} |
| 6. | edesedyjy69fed 02/02/2018 Nice News out - miRagen Therapeutics Presents New Data from Phase 1 Clinical Trial of MRG-106 in Mycosis Fungoides at the T-Cell Lymphoma Forum |
| 7. | brianpitkin 04/27/2018 miRagen Therapeutics Announces New Data Showing Administration of MRG-110 Improved Tissue Perfusion and Wound Healing in Late Stage Preclinical Studies |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Miragen Therapeutics, Inc.
- MGEN
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.